Stock Events

Stock Events

Co-Diagnostics 

$1.54
97
-$0.08-4.94% Thursday 20:00

Statistics

Day High
1.6
Day Low
1.45
52W High
46.5
52W Low
1.45
Volume
125,860
Avg. Volume
1,202,367
Mkt Cap
93.78M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q1 2024
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Next
-5.7
-3.87
-2.04
-0.21
Expected EPS
-3.75
Actual EPS
N/A

Financials

-961.4%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
7.83MRevenue
-75.28MNet Income

Analyst Ratings

$3.00Average Price Target
The highest estimate is 3.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
33%
Hold
67%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CODX. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Qiagen NV
QGEN
Mkt Cap10.16B
QIAGEN offers diagnostic solutions, including molecular diagnostics which directly compete with Co-Diagnostics' testing technologies.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific provides a broad range of diagnostic and research products, including molecular diagnostics that compete with CODX offerings.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories offers a variety of diagnostic tests and systems, including PCR-based tests, which are in direct competition with Co-Diagnostics' products.
Hologic
HOLX
Mkt Cap16.45B
Hologic specializes in diagnostics for women's health, including molecular diagnostics, competing in some of the same spaces as Co-Diagnostics.
Quest Diagnostics
DGX
Mkt Cap19.57B
Quest Diagnostics provides diagnostic testing services, including molecular diagnostics, competing with Co-Diagnostics in the laboratory testing market.
Labcorp
LH
Mkt Cap21.08B
Laboratory Corporation of America offers a wide range of diagnostic tests, including molecular diagnostics, making it a competitor in the diagnostics market.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories offers a broad portfolio of diagnostic products, including molecular diagnostics, competing across several of Co-Diagnostics' market segments.
Agilent Technologies
A
Mkt Cap41.49B
Agilent Technologies provides life sciences, diagnostics, and applied chemical markets with instruments and services, including diagnostics that compete with Co-Diagnostics.
Baxter International
BAX
Mkt Cap9.49B
Baxter International offers a range of medical devices and laboratory equipment, some of which are used in diagnostic applications that compete with Co-Diagnostics.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG is a major player in diagnostics and pharmaceuticals, including molecular diagnostics, making it a significant competitor to Co-Diagnostics in the global diagnostics market.

About

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
Show more...
CEO
Mr. Dwight H. Egan
Employees
132
Country
US
ISIN
US1897632048

Listings

LSE
GB
0A50.LSE
XNAS
US
CODX

0 Comments

Share your thoughts

FAQ

What is Co-Diagnostics stock price today?▼
The current price of CODX is $1.54 USD — it has decreased by -4.94% in the past 24 hours. Watch Co-Diagnostics stock price performance more closely on the chart.
What is Co-Diagnostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Co-Diagnostics stocks are traded under the ticker CODX.
Is Co-Diagnostics stock price growing?▼
CODX stock has fallen by -12% compared to the previous week, the month change is a -34.19% fall, over the last year Co-Diagnostics has showed a -84.11% decrease.
What is Co-Diagnostics market cap?▼
Today Co-Diagnostics has the market capitalization of 93.78M
When is the next Co-Diagnostics earnings date?▼
Co-Diagnostics is going to release the next earnings report on May 07, 2026.
What were Co-Diagnostics earnings last quarter?▼
CODX earnings for the last quarter are -4.8 USD per share, whereas the estimation was -5.7 USD resulting in a +15.79% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Co-Diagnostics revenue for the last year?▼
Co-Diagnostics revenue for the last year amounts to 7.83M USD.
What is Co-Diagnostics net income for the last year?▼
CODX net income for the last year is -75.28M USD.
How many employees does Co-Diagnostics have?▼
As of April 03, 2026, the company has 132 employees.
In which sector is Co-Diagnostics located?▼
Co-Diagnostics operates in the Health Care sector.
When did Co-Diagnostics complete a stock split?▼
The last stock split for Co-Diagnostics was on January 02, 2026 with a ratio of 1:30.
Where is Co-Diagnostics headquartered?▼
Co-Diagnostics is headquartered in Salt Lake City, US.